Abstract
The most frequent genetic changes found in lung tumors are activating point mutations in the K-Ras gene, which have been causally linked to the oncogenic process. Unfortunately, different approaches to directly target Ras proteins for therapy have sofar been unsuccessful. Therefore, in order to select better targets for lung cancer therapy, it will be necessary to identify K-Ras downstrea…